Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $11.0250 (-6.29%) ($11.0250 - $11.0250) on Wed. Feb. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.65% (three month average) | RSI | 40 | Latest Price | $11.0250(-6.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -5.2% a day on average for past five trading days. | Weekly Trend | TGTX declines -16% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(69%) IBB(67%) ARKK(64%) IWO(61%) | Factors Impacting TGTX price | TGTX will decline at least -4.325% in a week (0% probabilities). VIXM(-47%) VXX(-38%) UUP(-28%) UNG(-6%) USO(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.325% (StdDev 8.65%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.25(-274.6%) | Resistance Level | $14.14 | 5 Day Moving Average | $10.5(5%) | 10 Day Moving Average | $12.24(-9.93%) | 20 Day Moving Average | $14.14(-22.03%) | To recent high | -69% | To recent low | 30.1% | Market Cap | $1.396b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |